Federal award (BPA CALL, fiscal year 2022)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-05-08 to 2023-09-30
Current total value of award: $36739.49
Description: STANDARDS WILL BE USED FOR SCREENING AND ATION OF SUSPECTED DRUG USE IN SERVICE MEMBER AND/OR POST-MORTEM URINE, BLOOD AND TISSUE SAMPLES